Innova Captab Limited (INNOVACAP.NS)
INR 897.55
(2.5%)
INR 897.55
(2.5%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 3.46 Billion INR | 50.27% |
| 2022 | 2.34 Billion INR | 35.44% |
| 2021 | 1.73 Billion INR | 82.02% |
| 2020 | 952.55 Million INR | 8.38% |
| 2019 | 878.86 Million INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 951.06 Million INR | 0.88% |
| 2023 Q2 | 624.17 Million INR | -1.29% |
| 2023 Q3 | 1 Billion INR | 60.86% |
| 2023 Q1 | 632.3 Million INR | -59.95% |
| 2023 FY | 3.52 Billion INR | 50.27% |
| 2023 Q4 | 942.77 Million INR | -6.1% |
| 2022 Q3 | 652.15 Million INR | 0.0% |
| 2022 FY | 2.34 Billion INR | 35.44% |
| 2022 Q4 | 1.57 Billion INR | 142.06% |
| 2021 FY | 1.73 Billion INR | 82.02% |
| 2020 FY | 952.55 Million INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Hester Biosciences Limited | 1.27 Billion INR | -172.009% |
| RPG Life Sciences Limited | 2.48 Billion INR | -39.526% |
| Suven Pharmaceuticals Limited | 4.12 Billion INR | 15.978% |
| Ipca Laboratories Limited | 48.58 Billion INR | 92.869% |
| Aarti Drugs Limited | 8.31 Billion INR | 58.341% |
| Aarti Pharmalabs Limited | 5.83 Billion INR | 40.589% |
| Albert David Limited | 1.4 Billion INR | -146.039% |
| Alembic Limited | 1 Billion INR | -246.407% |
| Alkem Laboratories Limited | 52.29 Billion INR | 93.375% |
| Alembic Pharmaceuticals Limited | 26.78 Billion INR | 87.064% |
| Bafna Pharmaceuticals Limited | 452.15 Million INR | -666.21% |
| Bajaj HealthCare Limited | 1.47 Billion INR | -135.387% |
| Biofil Chemicals and Pharmaceuticals Limited | 12.54 Million INR | -27516.102% |
| Brooks Laboratories Limited | 65.62 Million INR | -5179.549% |
| Eris Lifesciences Limited | 10.42 Billion INR | 66.774% |
| FDC Limited | 6.58 Billion INR | 47.399% |
| Glenmark Life Sciences Limited | 12.43 Billion INR | 72.135% |
| Gufic Biosciences Limited | 4.07 Billion INR | 14.957% |
| Hikal Limited | 5.95 Billion INR | 41.852% |
| Ind-Swift Laboratories Limited | 4.13 Billion INR | 16.181% |
| Ind-Swift Limited | 2.17 Billion INR | -59.466% |
| IOL Chemicals and Pharmaceuticals Limited | 4.71 Billion INR | 26.587% |
| Jagsonpal Pharmaceuticals Limited | 652.59 Million INR | -430.875% |
| Jubilant Pharmova Limited | 19.64 Billion INR | 82.363% |
| Kilitch Drugs (India) Limited | 620.47 Million INR | -458.351% |
| Laurus Labs Limited | 15.44 Billion INR | 77.575% |
| Lincoln Pharmaceuticals Limited | 1.88 Billion INR | -83.608% |
| Lupin Limited | 125.09 Billion INR | 97.231% |
| Mangalam Drugs & Organics Limited | 691.19 Million INR | -401.226% |
| Medico Remedies Limited | 262.14 Million INR | -1221.579% |
| Morepen Laboratories Limited | 6.16 Billion INR | 43.771% |
| Nectar Lifesciences Limited | 4.82 Billion INR | 28.173% |
| Orchid Pharma Limited | 2.32 Billion INR | -49.31% |
| Procter & Gamble Health Limited | 5.78 Billion INR | 40.076% |
| Sigachi Industries Limited | 2 Billion INR | -73.024% |
| Solara Active Pharma Sciences Limited | -1.65 Billion INR | 309.218% |
| Sun Pharmaceutical Industries Limited | 258.48 Billion INR | 98.66% |
| Themis Medicare Limited | 2.42 Billion INR | -43.158% |
| Unichem Laboratories Limited | 4.86 Billion INR | 28.787% |
| Vaishali Pharma Limited | 90.32 Million INR | -3735.612% |
| Venus Remedies Limited | 2.18 Billion INR | -58.731% |
| Wanbury Limited | 1.73 Billion INR | -100.182% |
| Windlas Biotech Limited | 1.33 Billion INR | -158.772% |
| ZIM Laboratories Limited | 1.26 Billion INR | -173.261% |
| Sakar Healthcare Limited | 699.58 Million INR | -395.214% |
| Aurobindo Pharma Limited | 109.54 Billion INR | 96.837% |
| Divi's Laboratories Limited | 32.44 Billion INR | 89.32% |
| AstraZeneca Pharma India Limited | 6.22 Billion INR | 44.326% |
| Mankind Pharma Limited | 42.19 Billion INR | 91.79% |
| Sequent Scientific Limited | 2.97 Billion INR | -16.306% |
| Neuland Laboratories Limited | 8.24 Billion INR | 57.996% |
| J. B. Chemicals & Pharmaceuticals Limited | 15.25 Billion INR | 77.296% |
| Glenmark Pharmaceuticals Limited | 69.34 Billion INR | 95.004% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 97.233% |
| Amrutanjan Health Care Limited | 2.09 Billion INR | -65.443% |
| Wockhardt Limited | 7.72 Billion INR | 55.124% |
| Bal Pharma Limited | 770.19 Million INR | -349.813% |
| Dr. Reddy's Laboratories Limited | 163.6 Billion INR | 97.882% |
| Bliss GVS Pharma Limited | 3.69 Billion INR | 6.251% |
| Par Drugs and Chemicals Limited | 529.13 Million INR | -554.735% |
| Caplin Point Laboratories Limited | 9.2 Billion INR | 62.37% |
| Shilpa Medicare Limited | 3.56 Billion INR | 2.736% |
| Valiant Laboratories Limited | 138.02 Million INR | -2409.936% |
| Ajanta Pharma Limited | 21.06 Billion INR | 83.553% |
| Aarey Drugs & Pharmaceuticals Limited | 113.02 Million INR | -2965.089% |
| Granules India Limited | 16.79 Billion INR | 79.377% |
| Medicamen Biotech Limited | 495.49 Million INR | -599.188% |
| Syncom Formulations (India) Limited | 559.5 Million INR | -519.2% |
| Piramal Enterprises Limited | 8.04 Billion INR | 56.928% |
| Torrent Pharmaceuticals Limited | 46.75 Billion INR | 92.591% |
| NATCO Pharma Limited | 25.73 Billion INR | 86.539% |
| Suven Life Sciences Limited | -200.79 Million INR | 1825.345% |
| Krebs Biochemicals & Industries Limited | -108.74 Million INR | 3285.78% |
| Strides Pharma Science Limited | 14.38 Billion INR | 75.922% |
| Indoco Remedies Limited | 8.04 Billion INR | 56.926% |
| Alpa Laboratories Limited | 188.89 Million INR | -1734.056% |
| Lasa Supergenerics Limited | 121.02 Million INR | -2762.464% |
| Sun Pharma Advanced Research Company Limited | 391.06 Million INR | -785.896% |